N. Scott Fine

Filings by N. Scott Fine span 3 companies, the busiest being Cyclo Therapeutics, Inc., Central European Distribution Corp and Forward Industries, Inc. Between 24 January 2008 and 20 October 2023, the trades on record add up to 33 filings.

In open-market terms, that means 17 purchases worth €576k on one side and 2 sales worth €175k on the other. No amount is published for 6 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 11 share grants and 2 option exercises. In 2023 alone, the filings show 1 purchase and no sales.

The median purchase comes to €23k. 9 out of 10 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.

The latest filing, published on 23 October 2023, reports a share grant of €201k in Cyclo Therapeutics, Inc. The last insider purchase was made public on 24 April 2023, 1,279 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.